Cambridge Cancer Genomics (CCG) is a biotechnology company focused on revolutionizing cancer treatment through the implementation of precision oncology. CCG leverages advanced genomic technologies and machine learning algorithms to develop tools that predict patient response to cancer therapies and monitor treatment efficacy in real-time. Their platform aims to optimize treatment regimens, reduce ineffective interventions, and improve patient outcomes. Located in Cambridge, CCG works at the intersection of genomics, data science, and oncology to deliver cutting-edge solutions for personalized cancer care.